Larimar Therapeutics, Inc.
LRMR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374690
In the last 90 days, Larimar Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 163 institutions reported holding it in 13F filings for Q2 2026, worth $291.4M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Larimar Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 40 | 59 | +19 |
| Shares | 14.4M | 38.7M | +24.3M (+169.0%) |
| Value | $28.2M | $123.9M | +$95.7M (+339.0%) |
New holders (21)
Institutions that held Larimar Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Perceptive Advisors LLC | 2,860,000 | $9.15M | 0.27% |
| Woodline Partners LP | 1,941,739 | $6.21M | 0.09% |
| Great Point Partners LLC | 1,135,000 | $3.63M | 0.87% |
| Commodore Capital LP | 750,000 | $2.40M | 0.39% |
| CVI Holdings, LLC | 543,684 | $1.74M | 0.13% |
| Point72 Asset Management, L.P. | 475,000 | $1.52M | 0.01% |
| Altium Capital Management LP | 320,000 | $1.02M | 0.39% |
| Alyeska Investment Group, L.P. | 133,073 | $426.0K | 0.00% |
| Granite Point Capital Management, L.P. | 111,819 | $358.0K | 0.37% |
| Two Sigma Advisers, LP | 74,724 | $239.0K | 0.00% |
| Millennium Management LLC | 62,841 | $201.0K | 0.00% |
| Goldman Sachs Group Inc | 60,930 | $195.0K | 0.00% |
| Marshall Wace, LLP | 38,710 | $124.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 30,055 | $96.0K | 0.00% |
| Susquehanna International Group, LLP | 15,709 | $50.0K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 13,065 | $42.0K | 0.00% |
| Two Sigma Securities, LLC | 11,477 | $37.0K | 0.01% |
| Advisor Group Holdings, Inc. | 800 | $3.00K | 0.00% |
| China Universal Asset Management Co., Ltd. | 165 | $1.00K | 0.00% |
| Royal Bank of Canada | 42 | $0 | 0.00% |
| Simplex Trading, LLC | 306 | $0 | 0.00% |
Sold out (2)
Institutions that held Larimar Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Ra Capital Management, L.P. | 1,031,482 | $2.02M |
| Ikarian Capital, LLC | 51,606 | $100.0K |